193 related articles for article (PubMed ID: 26431381)
1. Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.
Yao PL; Chen LP; Dobrzański TP; Phillips DA; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Oncotarget; 2015 Nov; 6(34):36319-37. PubMed ID: 26431381
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
[TBL] [Abstract][Full Text] [Related]
3. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
4. Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.
Borland MG; Yao PL; Kehres EM; Lee C; Pritzlaff AM; Ola E; Wagner AL; Shannon BE; Albrecht PP; Zhu B; Kang BH; Robertson GP; Gonzalez FJ; Peters JM
Toxicol Sci; 2017 Oct; 159(2):436-448. PubMed ID: 28962521
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.
Borland MG; Kehres EM; Lee C; Wagner AL; Shannon BE; Albrecht PP; Zhu B; Gonzalez FJ; Peters JM
Toxicology; 2018 Jul; 404-405():25-32. PubMed ID: 29729928
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
Berry DC; Noy N
Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
[TBL] [Abstract][Full Text] [Related]
7. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
8. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
Schug TT; Berry DC; Toshkov IA; Cheng L; Nikitin AY; Noy N
Proc Natl Acad Sci U S A; 2008 May; 105(21):7546-51. PubMed ID: 18495924
[TBL] [Abstract][Full Text] [Related]
9. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P; McAndrews DJ; Mohiudddin IQ
BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ).
Yu S; Levi L; Siegel R; Noy N
J Biol Chem; 2012 Dec; 287(50):42195-205. PubMed ID: 23105114
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335
[TBL] [Abstract][Full Text] [Related]
12. The Role of PPARβ/δ in Melanoma Metastasis.
Lim JCW; Kwan YP; Tan MS; Teo MHY; Chiba S; Wahli W; Wang X
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241392
[TBL] [Abstract][Full Text] [Related]
13. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
14. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM
Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674
[TBL] [Abstract][Full Text] [Related]
15. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters JM; Kim DJ; Bility MT; Borland MG; Zhu B; Gonzalez FJ
Mol Carcinog; 2019 Sep; 58(9):1612-1622. PubMed ID: 31062422
[TBL] [Abstract][Full Text] [Related]
16. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
Ritzenthaler JD; Roman J; Han S
Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
[TBL] [Abstract][Full Text] [Related]
17. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ.
da Cruz BO; Cardozo LFMF; Magliano DC; Stockler-Pinto MB
Nutr Rev; 2020 Mar; 78(3):207-214. PubMed ID: 31584650
[TBL] [Abstract][Full Text] [Related]
18. Establishing the Role of PPARβ/δ in Carcinogenesis.
Peters JM; Gonzalez FJ; Müller R
Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
[TBL] [Abstract][Full Text] [Related]
19. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
20. A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Genovese S; Foreman JE; Borland MG; Epifano F; Gonzalez FJ; Curini M; Peters JM
Life Sci; 2010 Mar; 86(13-14):493-8. PubMed ID: 20153754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
